Buys
Open market- Shares
- Avg price
- Total value
Erik Harris - EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc.
Issuer-level insider activity
- Role
- EVP & Chief Commercial Officer
- Issuer ticker
- RARE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Erik Harris in Ultragenyx Pharmaceutical Inc.
Sells
Open market- Shares
- -10,539
- Avg price
- $22.80
- Total value
- -$240,289
Net
Past year- Shares
- -10,539
- Share %
- -100%
- Total value
- -$240,289
Reported holdings for Erik Harris in Ultragenyx Pharmaceutical Inc.
Form 4 holding
EVP & Chief Commercial Officer
Ultragenyx Pharmaceutical Inc.
- Security class
- Common Stock
- Shares / value
- 118,410
- Estimated value
- $2,480,689
- Report date
- 16 Apr 2026
- Price
- $20.95
- Ownership
- Direct
Form 4 holding
EVP & Chief Commercial Officer
Ultragenyx Pharmaceutical Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 49,960
- Estimated value
- Report date
- 16 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Erik Harris in Ultragenyx Pharmaceutical Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.